Both pharmaceutical companies and insurers agree that increased communication could help address the high cost of specialty drugs. (aaas.org)
Today, the market for specialty drugs is over 120 billion dollars, with annual growth estimated at nearly 9 %. (rxadvance.com)
While insurers have been imposing higher cost - sharing requirements as part of their efforts to manage specialty drug spending, there has been limited information about the corresponding impact on patients. (sciencedaily.com)